Thrivent Financial for Lutherans Sells 774,647 Shares of Maximus, Inc. (NYSE:MMS)

Thrivent Financial for Lutherans decreased its position in shares of Maximus, Inc. (NYSE:MMS) by 97.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,948 shares of the health services provider’s stock after selling 774,647 shares during the period. Thrivent Financial for Lutherans’ holdings in Maximus were worth $1,858,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of MMS. Natixis Advisors LLC acquired a new position in shares of Maximus during the 3rd quarter worth about $955,000. Entropy Technologies LP bought a new stake in shares of Maximus in the third quarter valued at approximately $214,000. Versor Investments LP increased its position in Maximus by 213.5% during the third quarter. Versor Investments LP now owns 8,500 shares of the health services provider’s stock worth $792,000 after acquiring an additional 5,789 shares during the period. Crossmark Global Holdings Inc. boosted its holdings in Maximus by 9.8% in the 3rd quarter. Crossmark Global Holdings Inc. now owns 4,152 shares of the health services provider’s stock valued at $387,000 after purchasing an additional 369 shares during the period. Finally, Covestor Ltd grew its position in Maximus by 913.0% in the 3rd quarter. Covestor Ltd now owns 1,246 shares of the health services provider’s stock worth $116,000 after purchasing an additional 1,123 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Maximus news, insider Michelle F. Link sold 1,363 shares of the stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total value of $126,159.28. Following the transaction, the insider now directly owns 6,567 shares in the company, valued at approximately $607,841.52. This trade represents a 17.19 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.40% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com lowered shares of Maximus from a “buy” rating to a “hold” rating in a research report on Thursday.

Maximus Price Performance

Shares of MMS stock opened at $72.50 on Friday. The stock has a 50 day moving average of $87.17 and a two-hundred day moving average of $87.75. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.59. The company has a market capitalization of $4.37 billion, a P/E ratio of 14.50 and a beta of 0.77. Maximus, Inc. has a 12 month low of $71.75 and a 12 month high of $93.97.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Saturday, November 30th. Investors of record on Friday, November 15th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, November 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.66%. Maximus’s dividend payout ratio (DPR) is presently 24.00%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.